TVTX Next Earnings Date Notes

— Travere Therapeutics (NASDAQ: TVTX) is a biopharmaceutical company focused on developing & commercializing therapies for rare diseases, particularly those affecting the kidney, liver, and metabolic systems. The company’s flagship product is Filspari (sparsentan), approved for kidney diseases like IgA nephropathy. When evaluating TVTX's long-term potential, investors should track several key business metrics: net product revenue (with emphasis on Filspari's growth trajectory), R&D expense (reflecting pipeline investment), cash runway (total cash, cash equivalents, & marketable securities), and regulatory milestones or updates on late-stage clinical programs. Pipeline progress—especially clinical trial results—can have major impacts on valuation, as future revenue growth is closely tied to success in expanding indications or launching new therapies. Listening for management guidance on market uptake, payer coverage, and new patient starts for Filspari is wise, since these metrics signal commercial execution. In addition, take note of any partnership or licensing agreements, as these can provide non-dilutive capital & validate TVTX's science. In summary, product revenue, clinical development milestones, & cash position are most critical for assessing Travere's trajectory. The next projected earnings date for TVTX is 10/29/2026 after close (stay tuned for a confirmed earnings date once announced).

TVTX Next Earnings Date FAQ

On this page we presented the TVTX Next Earnings Date information for Travere Therapeutics along with recent past earnings dates. For Q2 of 2026, TVTX reported earnings of -0.100/share, with the earnings report taking place on 8/4/2026. For Q1 of 2026, TVTX reported earnings of 0.050/share, with the earnings report taking place on 5/4/2026. For Q4 of 2025, TVTX reported earnings of 0.370/share, with the earnings report taking place on 2/19/2026. For Q3 of 2025, TVTX reported earnings of 0.590/share, with the earnings report taking place on 10/30/2025. For Q2 of 2025, TVTX reported earnings of 0.130/share, with the earnings report taking place on 8/6/2025. Based on these past earnings dates, the projected next earnings date for TVTX is 10/29/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Travere Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Travere Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Travere Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next TVTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up TVTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the TVTX next earnings date.